[This corrects the article DOI: 10.3389/fimmu.2023.1118039.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11027428 | PMC |
| http://dx.doi.org/10.3389/fimmu.2024.1383797 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX" [Multiple Sclerosis and Related Disorders (2020) 1;38:101506].
Mult Scler Relat Disord
January 2025
Division of Neurology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Corrigendum to "Dose dependent safety implications and acute intravenous toxicity of aminocellulose-grafted-polycaprolactone coated gelatin nanoparticles in mice" [Int. J. Biol. Macromol. 192 (2021) 1150-1159].
Int J Biol Macromol
January 2025
Laboratory for Stem Cell & Restorative Neurology, Department of Biotechnology, Era's Lucknow Medical College and Hospital, Sarfarazganj, Lucknow 226003, Uttar Pradesh, India.
Corrigendum to "Dynamic changes in serum (1-3)-β-D-glucan caused by intravenous immunoglobulin infusion: A prospective study" [Diagnostic Microbiology and Infectious Disease Volume 109, Issue 4, August 2024, 116328].
Diagn Microbiol Infect Dis
November 2024
Medical Intensive Care Unit, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.
Corrigendum: Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunodeficiency.
Front Immunol
May 2024
Global Medical Department, Bio Products Laboratory, Ltd., Elstree, United Kingdom.
[This corrects the article DOI: 10.3389/fimmu.2022.
View Article and Find Full Text PDFCorrigendum to "Intravenous immunoglobulin alleviates Japanese encephalitis virus-induced peripheral neuropathy by inhibiting the ASM/ceramide pathway" [Int. Immunopharmacol. 133 (2024) 112083].
Int Immunopharmacol
June 2024
Neurology Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China; Institute of Medical Sciences, General Hospital of Ningxia Medical University, Diagnosis and Treatment Engineering Technology Research Center of Nervous System Diseases of Ningxia Hui Autonomous Region, Yinchuan, China. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!